Search our site RxMed


Valuable information for over 200 common illnesses
Patient Illnesses
Pharmaceutical Information
Travel Illness Info
About RxMed
Our Medical Advisory Board
General Illness Information

Common Name:

Hodgkin's disease

Medical Term:

Hodgkin's disease
Description:

A malignant disease of the lymphoid tissue

Involves lymph glands, white cells (lymphocytes) and the spleen.

May present as a localized or generalized form of cancer.

Has two age distribution patterns--- One between the ages of 15 to 34 and the other after the age of 60.

Rare in children under 10.

 

 

Causes:

Unknown.

Viruses may be implicated.

 

 

Prevention:

No specific preventive measures

Signs & Symptoms
Enlarged non-tender lymph nodes, especially in the neck.

Unexplained Fever 

Night sweats

Weight loss

Fatigue

Anorexia

Unexplained itching

Alcohol-induced pain

 

Risk Factors

Immunodeficiency (inherited or acquired)

Autoimmune disorders

HIV infection

 

Diagnosis & Treatment

Diagnostic tests may include laboratory studies of blood and bone marrow, lymphangiogram, biopsy of lymph node, CT scan of chest and abdomen, and chest X-ray.


General Measures:
Treatment aimed for cure with minimum toxicity, including treatment-induced late mortality

· Treatment can be radiation therapy , chemotherapy, or combined radiation and chemotherapy , based on stage and tumor pathology.

 

Medications:
· Note: Must be monitored by experienced oncologist

ABVD chemotherapy - 4 week cycles

Doxorubicin (Adriamycin) - 25 mg/m2 IV days 1 and 15

Bleomycin 10 mg/m2 IV days 1 and 15

Vinblastine 6.0 mg/m2 IV days 1 and 15

Dacarbazine 375 mg/m2 IV days 1 and 15

Repeat cycles at least 6 times if blood counts permit

 

Activity:
No restrictions
Diet:
No restrictions
Possible Complications :
Secondary malignancies following therapy

Sterility.

Hypothyroidism

Bone marrow suppression

Infections, including herpes zoster

Anemia

Platelet failure.

Coronary artery disease, cardiomyopathy

Radiation pneumonitis, pulmonary fibrosis

Transient radiation myelopathy.

 

Prognosis

Overall 5 year survival 82%

75% long term survival

10 year survival rates correlate with stage at diagnosis.